sulfasalazine has been researched along with Uveitis in 6 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of sulfasalazine (SSZ) in the prevention of recurrent flares of acute anterior uveitis (AAU)." | 9.10 | Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. ( Bonilla, G; Fernández-Melón, J; Fonseca, A; Gijón-Baños, J; Hidalgo, V; Martín-Mola, E; Muñoz-Fernández, S; Ruiz-Sancho, D; Schlincker, A, 2003) |
| "To evaluate the efficacy of sulfasalazine (SSZ) in the prevention of recurrent flares of acute anterior uveitis (AAU)." | 5.10 | Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. ( Bonilla, G; Fernández-Melón, J; Fonseca, A; Gijón-Baños, J; Hidalgo, V; Martín-Mola, E; Muñoz-Fernández, S; Ruiz-Sancho, D; Schlincker, A, 2003) |
| " First-line sulfasalazine reduced uveitis relapses." | 3.96 | Impact of systemic treatments on the course of HLA-B27-associated uveitis: A retrospective study of 101 patients. ( Bouzid, N; Chapurlat, R; De Parisot, A; Jamilloux, Y; Kodjikian, L; Pradat, P; Sève, P, 2020) |
| "Uveitis is a prevalent disease that mainly affects young people." | 2.43 | Uveitis. ( Martín-Mola, E; Muñoz-Fernández, S, 2006) |
| "Age and uveitis are related to conversion to biologics therapy." | 1.91 | Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment. ( Huang, D; Huang, W; Luo, L; Ren, F; Tang, L; Zhang, Z; Zhou, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, J | 1 |
| Huang, W | 1 |
| Zhang, Z | 1 |
| Luo, L | 1 |
| Ren, F | 1 |
| Huang, D | 1 |
| Tang, L | 1 |
| Bouzid, N | 1 |
| Jamilloux, Y | 1 |
| Chapurlat, R | 1 |
| Pradat, P | 1 |
| De Parisot, A | 1 |
| Kodjikian, L | 1 |
| Sève, P | 1 |
| Silva-Fernández, L | 1 |
| Pérez-Vicente, S | 1 |
| Martín-Martínez, MA | 1 |
| López-González, R | 1 |
| Castro Villegas, Mdel C | 1 |
| Escudero Contreras, A | 1 |
| Miranda García, MD | 1 |
| Collantes Estévez, E | 1 |
| Muñoz-Fernández, S | 2 |
| Hidalgo, V | 1 |
| Fernández-Melón, J | 1 |
| Schlincker, A | 1 |
| Bonilla, G | 1 |
| Ruiz-Sancho, D | 1 |
| Fonseca, A | 1 |
| Gijón-Baños, J | 1 |
| Martín-Mola, E | 2 |
2 reviews available for sulfasalazine and Uveitis
| Article | Year |
|---|---|
[How to optimize the antiTNF alpha therapy in spondylitis?].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheu | 2012 |
Uveitis.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Disease | 2006 |
1 trial available for sulfasalazine and Uveitis
| Article | Year |
|---|---|
Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Female; Huma | 2003 |
3 other studies available for sulfasalazine and Uveitis
| Article | Year |
|---|---|
Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biological Factors; Biolo | 2023 |
Impact of systemic treatments on the course of HLA-B27-associated uveitis: A retrospective study of 101 patients.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Female; HLA-B27 Antigen; Humans; | 2020 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclospo | 2015 |